Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Hisamitsu Pharmaceutical Co ( (JP:4530) ) just unveiled an announcement.
Hisamitsu Pharmaceutical Co., Inc. has secured shareholder approval for a share consolidation that will result in its common stock meeting the delisting criteria of the Tokyo, Nagoya and Fukuoka stock exchanges. As a consequence, the company’s shares are scheduled to be delisted on May 11, 2026, ending their trading on these markets.
The company emphasized its gratitude to shareholders and related parties for their long-standing support as it transitions off the exchanges. Management also reiterated its commitment to improving corporate value, signaling that strategic and operational initiatives will continue despite the move away from public listings.
The most recent analyst rating on (JP:4530) stock is a Hold with a Yen4300.00 price target. To see the full list of analyst forecasts on Hisamitsu Pharmaceutical Co stock, see the JP:4530 Stock Forecast page.
More about Hisamitsu Pharmaceutical Co
Hisamitsu Pharmaceutical Co., Inc. is a Japanese pharmaceutical company listed on the Tokyo, Nagoya and Fukuoka exchanges, known for developing and marketing medicines and related healthcare products. The company focuses on enhancing corporate value through its operations and maintains a broad base of shareholders and stakeholders in Japan’s capital markets.
Average Trading Volume: 485,076
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen440.7B
Learn more about 4530 stock on TipRanks’ Stock Analysis page.